<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00737412</url>
  </required_header>
  <id_info>
    <org_study_id>CL1285-TD-M02</org_study_id>
    <nct_id>NCT00737412</nct_id>
  </id_info>
  <brief_title>Efficacy of BIO-K+ CL1285® Prophylaxis in the Prevention of Traveler's Diarrhea in Adults</brief_title>
  <official_title>A Double-blind, Randomized, Placebo Controlled, Multicenter Study of the Efficacy of BIO-K+ CL1285® Prophylaxis in the Prevention of Traveler's Diarrhea in Adults.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bio-K Plus International Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>ethica Clinical Research Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Bio-K Plus International Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the efficacy of Bio-K+ CL1285 in reducing
      traveler's diarrhea.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Determine efficacy of Bio-K+ CL1285 in reducing Traveler's Diarrhea by comparing the
      incidence of diarrhea in travelers during their stay abroad and upon their return to Canada
      following either Bio-K+ CL-1285 OR placebo prophylaxis.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2008</start_date>
  <completion_date type="Actual">January 2010</completion_date>
  <primary_completion_date type="Actual">December 2009</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To determine the efficacy of Bio-K+ CL1285 RX® in reducing traveler's diarrhea by comparing the incidence of diarrhea in travelers during their stay abroad and upon their return to Canada, following either BIO-K+CL1285 RX® or placebo prophylaxis.</measure>
    <time_frame>March 2008 to April 2009</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To compare the severity of diarrhea in travelers during their stay abroad and upon their return to Canada, following either BIO-K+CL1285 RX® or placebo prophylaxis.</measure>
    <time_frame>March 2008 to April 2009</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To compare the safety profile of BIO-K+CL1285 RX® to that of placebo</measure>
    <time_frame>March 2008 to April 2009</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To compare the physician and traveler satisfaction following daily prophylaxis with either BIO-K+CL1285 RX® or placebo</measure>
    <time_frame>March 08 to April 09</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To evaluate and compare the health economic impact of daily prophylaxis with BIO-K+CL1285 RX®.</measure>
    <time_frame>March 08 to April 09</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">277</enrollment>
  <condition>Diarrhea</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The probiotic Bio-K+ CL1285 RX®</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Probiotic: Bio-K+ CL1285</intervention_name>
    <description>The probiotic Bio-K+ CL1285 RX®, a mixture of Lactobacillus acidophilus and Lactobacillus casei, contains over 50 billion living bacteria per administered dose.</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Bio-K+ CL1285 RX®</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Matching capsules devoid of microorganisms</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female subjects over 18 years of age traveling to Mexico, Central America,
             South America and Caribbean Islands as direct destinations or on cruises to the same
             destinations.

          -  The trips last a minimum of 7 days and a maximum of 21 days.

          -  Women of child bearing capacity who are not pregnant at the moment of screening
             (pregnancy test done on-site) and agree to use an acceptable form of birth control for
             the duration of the study (e.g. Condom, oral contraceptives, etc.) are allowed to
             participate.

        Exclusion Criteria:

          -  active diarrhea;

          -  pregnancy; breastfeeding

          -  3 diarrheic episodes within 24 hours in the 15 days preceding the date of the
             departure;

          -  antibiotic treatment during the last 15 days or ongoing treatment at the time of
             departure;

          -  consumption of fermented milk, yogourt or probiotics probiotics in the 15 days
             preceding the date of the departure;

          -  immunosuppressed state or any health condition being susceptible to decompensate
             during the study (including malignant hemo-pathologies, AIDS, bone marrow transplant
             or organ transplant).

          -  active radiotherapy or chemotherapy as cancer treatment

          -  the administration of an ETEC/cholera vaccine or any other diarrhea vaccine in the
             three months prior to study initiation

          -  an active, non-controlled intestinal disease;

          -  ileostomy, jejunostomy or colostomy

          -  concomitant participation in another clinical trial

          -  mental or other conditions, or language barriers rendering the subject unable to
             understand the nature, scope, and possible consequences of the study or complete the
             self-administered questionnaires;

          -  subject unlikely to comply with protocol, e.g., uncooperative attitude, and
             unlikelihood of completing the study,

          -  allergies to any ingredients in the study product (active product or placebo)

          -  current use of illicit drug and alcohol abuse
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dominique Tessier, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sante Voyage Medisys</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Benoit Brizard, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinique Santé Voyage de Laval</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Benoit Cote, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinique Sante Voyage des Prairies</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jean Vincelette, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sante Voyage Saint-Luc</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Clinique Santé Voyage des Prairies</name>
      <address>
        <city>Joliette</city>
        <state>Quebec</state>
        <zip>J6E 1G2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Santé Voyage de Laval</name>
      <address>
        <city>Laval</city>
        <state>Quebec</state>
        <zip>H7G2E6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Santé Voyage Saint-Luc</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H2X 2H9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sant Voyage Medisys</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H3A 3C6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>January 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 15, 2008</study_first_submitted>
  <study_first_submitted_qc>August 18, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 19, 2008</study_first_posted>
  <last_update_submitted>January 19, 2010</last_update_submitted>
  <last_update_submitted_qc>January 19, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 21, 2010</last_update_posted>
  <responsible_party>
    <name_title>Marcia T. Ruiz</name_title>
    <organization>Bio-K+ International Inc.</organization>
  </responsible_party>
  <keyword>Bio-K+CL1285</keyword>
  <keyword>Probiotics</keyword>
  <keyword>Traveler's Diarrhea</keyword>
  <keyword>Lactobacillus Acidophilus</keyword>
  <keyword>Lactobacillus Casei</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diarrhea</mesh_term>
    <mesh_term>Dysentery</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>January 14, 2016</submitted>
    <returned>February 11, 2016</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

